Taysha Gene Therapies Inc... (TSHA)
NASDAQ: TSHA
· Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.88%
After-hours: Aug 15, 2025, 07:17 PM EDT
Taysha Gene Therapies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 8.1M | 7.22M | 8.33M | 9.91M | 12.87M | 14.16M | 15.45M | 14.35M | 9.6M | 7.21M | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 277K | n/a | 325K | 691K | 1.02M | 1.73M | 2.03M | 3.34M | 3.31M | 2.91M | 2.54M | 1.07M | 932K | 717K | 492K | 283K | 117K | 32K |
Gross Profit | 7.82M | 7.22M | 8.33M | 9.55M | 12.18M | 12.76M | 13.42M | 11.01M | 6.29M | 4.3M | -34K | -1.07M | -932K | -717K | -492K | -283K | -117K | -32K |
Operating Income | -94M | -88.55M | -91.46M | -87.77M | -78.13M | -80.21M | -72.44M | -111.31M | -120.14M | -129.74M | -162.45M | -157.05M | -182.66M | -190.44M | -173.27M | -141.91M | -106.27M | -69.51M |
Interest Income | 6.99M | 6.57M | 6.94M | 7.16M | 6.16M | 4.95M | 3.57M | 1.85M | 750K | 554K | 249K | 79K | 107K | 120K | 172K | 143K | 106K | 66K |
Pretax Income | -92.72M | -86.77M | -89.3M | -22.77M | -114.33M | -118M | -111.57M | -215.03M | -124.25M | -133.53M | -166.01M | -160.68M | -185.56M | -192.61M | -174.52M | -142.46M | -106.31M | -86.6M |
Net Income | -92.72M | -86.77M | -89.3M | -22.77M | -114.33M | -118M | -114M | -219.8M | -130.25M | -140.42M | -171.31M | -163.64M | -187.29M | -193.45M | -174.52M | -142.46M | -106.31M | -86.6M |
Selling & General & Admin | 31.29M | 30.03M | 28.95M | 29.04M | 29.73M | 28.38M | 30.05M | 30.67M | 30.76M | 34.64M | 37.36M | 41.83M | 44.3M | 44.56M | 41.32M | 35.63M | 28.46M | 19.27M |
Research & Development | 65.98M | 60.91M | 66M | 63.36M | 60.2M | 64.92M | 56.78M | 57.96M | 62.56M | 65.88M | 91.17M | 115.23M | 138.36M | 145.89M | 131.94M | 106.28M | 77.81M | 50.23M |
Other Expenses | 4.84M | 4.84M | 4.84M | 5.29M | 1.06M | 1.07M | 1.06M | 605K | -12K | -18K | -18K | -12K | -11K | -8K | n/a | n/a | n/a | n/a |
Operating Expenses | 102.1M | 95.77M | 99.79M | 97.69M | 91M | 94.37M | 87.89M | 89.24M | 93.32M | 100.53M | 128.53M | 157.05M | 182.66M | 190.44M | 173.27M | 141.91M | 106.27M | 69.51M |
Interest Expense | 82K | 92K | 102K | 793K | 2.24M | 3.65M | 5M | 5.08M | 4.69M | 3.99M | 3.29M | 3.18M | 2.65M | 2.1M | 1.43M | 737K | 195K | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 102.1M | 95.77M | 99.79M | 97.69M | 91M | 94.37M | 87.89M | 89.24M | 93.32M | 100.53M | 128.53M | 157.05M | 182.66M | 190.44M | 173.27M | 141.91M | 106.27M | 69.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 2.44M | 4.77M | 6M | 6.89M | 5.3M | 2.96M | 1.77M | 920K | 143K | 192K | 152K | 112K |
Shares Outstanding (Basic) | 297.99M | 269.31M | 250.13M | 267.82M | 232.82M | 231.25M | 186.96M | 251.4M | 256.98M | 253.04M | 225.54M | 163.75M | 160.57M | 152.7M | 152.44M | 152.02M | 149.92M | 147.97M |
Shares Outstanding (Diluted) | 297.99M | 269.31M | 250.13M | 267.82M | 232.82M | 231.25M | 186.96M | 251.4M | 256.98M | 253.04M | 225.54M | 163.75M | 160.57M | 152.7M | 152.44M | 152.02M | 149.92M | 147.97M |
EPS (Basic) | -0.34 | -0.34 | -0.36 | -0.03 | -0.45 | -0.74 | -0.96 | -2.25 | -2.4 | -2.89 | -3.9 | -4.19 | -4.87 | -5.09 | -4.63 | -4.35 | -4.28 | -3.8 |
EPS (Diluted) | -0.34 | -0.34 | -0.36 | -0.03 | -0.45 | -0.74 | -0.96 | -2.25 | -2.4 | -2.89 | -3.9 | -4.19 | -4.87 | -5.09 | -4.63 | -4.35 | -4.28 | -3.8 |
EBITDA | -91.64M | -85.47M | -87.95M | -20.67M | -110.75M | -112.63M | -104.54M | -206.6M | -116.5M | -127.03M | -160.8M | -157.04M | -182.34M | -190M | -172.6M | -141.43M | -105.99M | -86.56M |
EBIT | -92.64M | -86.67M | -89.2M | -21.98M | -112.09M | -114.35M | -106.57M | -209.95M | -119.4M | -129.2M | -162.22M | -156.98M | -182.56M | -190.33M | -173.09M | -141.72M | -106.11M | -86.6M |
Depreciation & Amortization | 1.16M | 1.2M | 1.25M | 1.31M | 1.34M | 1.73M | 2.03M | 3.34M | 3.31M | 2.91M | 2.54M | 1.07M | 932K | 717K | 492K | 289K | 126K | 4.05M |